Nordhealth AS completes share buyback program

With reference to the share buyback program announced 5 June 2023, Nordhealth AS (”the Company”) has reached the buyback program’s maxiumum consideration of NOK 4 million as of 30 June. Under the share buyback program the Company purchased 154,013 of its own shares in the period 5 June 2023 to 30 June 2023 at an average price of NOK 25.9717 per share for a total consideration of NOK 3,999,975.21.

From 23 June 2023 until 30 June 2023, Nordhealth purchased a total of 35,800 own shares at an average price of NOK 27.0956 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
23/06/2023 12,578 28.0549 352,874.53
26/06/2023 4,972 27.1079 134,780.48
27/06/2023 3,470 27.3050 94,748.35
28/06/2023 6,193 26.0840 161,538.21
29/06/2023 6,605 26.4164 174,480.32
30/06/2023 1,982 26.0345 51,600.38
Previously disclosed buy-backs under the programme (aggregate) 118,213 25.6313 3,029,952.94
Total purchased under the programme 154,013 25.9717 3,999,975.21

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For further information, please contact:

Charles Macbain, CEO

Mari Orttenvuori, CFO

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 380 employees working either remotely or from offices (collaboration hubs). Visit the company’s website at

NORDH - Buy back - 30 June 2023.pdf